Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-08-09FDA Approved: RISPERIDONE — Supplemental Application (Amici Pharma, Inc.)
The FDA approved Amici Pharma, Inc.'s supplemental application for risperidone, authorizing a generic version of the antipsychotic under an …
-
CLINICAL_TRIALS research · 2011-08-04Clinical Trial Update: Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications [NA]
A completed clinical trial evaluated an exercise and diet program for schizophrenia patients treated with atypical antipsychotic medications…
-
CLINICAL_TRIALS trial_result · 2011-08-02Clinical Trial Update: Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluating omega-3 fatty acid deficiency replacement in early schizophrenia, sponsored by the Uni…
-
CLINICAL_TRIALS trial_result · 2011-08-01Clinical Trial Update: Safety Study of Sertindole Versus Risperidone Under Normal Conditions of Use [Phase 3]
Phase 3 safety study comparing sertindole with risperidone under normal conditions of use in schizophrenia; results were posted.
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder [Phase 2, Phase 3]
The document reports on a clinical trial studying how ziprasidone affects glucose and lipid parameters in people with diabetes and in those …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-28Clinical Trial Update: Magnetic Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia [Phase 4]
This clinical trial update reports a Phase 4 investigation of magnetic stimulation for treating auditory hallucinations in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism [Phase 4]
A Phase 4 trial compares chronic olanzapine versus risperidone and assesses their effects on glucose and lipid metabolism in schizophrenia p…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine [Phase 4]
Phase 4 clinical trial evaluating the interaction between clozapine and fluvoxamine in treatment-refractory schizophrenia. The study highlig…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients
Completed clinical trial evaluating how atypical antipsychotics influence appetite and eating behavior in people with schizophrenia and schi…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome [Phase 3]
Phase 3 trial comparing aripiprazole with standard of care on non-HDL cholesterol in adults with schizophrenia or bipolar I disorder and met…
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 trial update assessing cataract risk associated with quetiapine (Seroquel) and risperidone (Risperdal) in people with schizophrenia …
-
FDA approval · 2011-07-11FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)
FDA approves a supplemental application for Risperidone by Zydus Lifesciences Limited, confirming regulatory approval of changes to the prod…
-
CLINICAL_TRIALS trial_result · 2011-07-11Clinical Trial Update: D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia [Phase 2]
A Phase 2 trial evaluating D-amino Acid Oxidase Inhibition (DAAOI-1) as an add-on treatment for chronic schizophrenia has completed.
-
FDA approval · 2011-07-08FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for SEROQUEL (quetiapine) submitted by H2-Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2011-07-08Clinical Trial Update: A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder [NA]
Clinical trial update about a follow-up study of intramuscular olanzapine depot in patients with schizophrenia or schizoaffective disorder. …
-
FDA approval · 2011-06-30FDA Approved: RISPERIDONE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approves a supplemental application for generic risperidone by Jubilant Cadista Pharmacuticals Inc., enabling the generic product to…
-
FDA approval · 2011-06-30FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals, LLC's supplemental application for risperidone (RISPERIDONE). This action approves the generic pro…
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia [Phase 4]
A Phase 4, placebo-controlled single-dose trial of sildenafil in schizophrenia conducted by Massachusetts General Hospital has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-28Clinical Trial Update: Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics [Phase 1]
The study reports the completion of a Phase 1 safety, tolerability, and pharmacokinetics evaluation of ACP-104 in schizophrenia.
-
CLINICAL_TRIALS research · 2011-06-28Clinical Trial Update: The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours
A completed AstraZeneca-sponsored study aimed to gain an in-depth understanding of patient management and prescription behaviours in schizop…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: The Compliance Project Concerning People With Schizophrenia [NA]
A Danish government-sponsored trial on compliance in people with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Phase IIA Study in Patients With Schizophrenia [Phase 2]
A Phase IIa study in schizophrenia conducted by AstraZeneca has completed, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Evaluation of Dorsal Visual Stream in Patients With Schizophrenia
The study evaluating the dorsal visual stream function in patients with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study [Phase 4]
Phase 4 pilot trial evaluating the efficacy and safety of quetiapine for affective symptoms in patients with first-episode psychosis (schizo…
-
FDA approval · 2011-06-15FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals.